|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 5/0783 | (2010.01) |
| A01N 1/02 | (2006.01) | ||
| A61K 35/17 | (2015.01) | ||
| C12M 3/00 | (2006.01) |
| (11) | Number of the document | 3775165 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18745741.1 |
| Date of filing the European patent application | 2018-06-29 | |
| (97) | Date of publication of the European application | 2021-02-17 |
| (45) | Date of publication and mention of the grant of the patent | 2024-03-27 |
| (46) | Date of publication of the claims translation | 2024-07-10 |
| (86) | Number | PCT/US2018/040474 |
| Date | 2018-06-29 |
| (87) | Number | WO 2019/190579 |
| Date | 2019-10-03 |
| (30) | Number | Date | Country code |
| 201815940901 | 2018-03-29 | US |
| (72) |
WARDELL, Seth , US
BENDER, James , US
|
| (73) |
Iovance Biotherapeutics, Inc. ,
825 Industrial Road
Suite 400, San Carlos, CA 94070,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Naviką infiltruojančių limfocitų gamybos būdas ir jų panaudojimas imunoterapijai |
| PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY |
| Payment date | Validity (years) | Amount | |
| 2025-06-02 | 8 | 185.00 EUR |
| 2026-06-29 |